Safety Study of NNZ-2566 in Healthy Female Subjects
NCT00961779
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Brain Injuries, Traumatic
Interventions
DRUG:
NNZ-2566
DRUG:
Placebo
Sponsor
Neuren Pharmaceuticals Limited